228 related articles for article (PubMed ID: 8171416)
1. Neutralization of the anticoagulant activity of low molecular weight heparin LU 47311 (Clivarin) in man by protamine chloride.
Andrassy K; Eschenfelder V; Weber E
Thromb Res; 1994 Jan; 73(2):85-93. PubMed ID: 8171416
[TBL] [Abstract][Full Text] [Related]
2. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
[TBL] [Abstract][Full Text] [Related]
3. The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effects.
Harenberg J; Stehle G; Dempfle CE; von Hodenberg E; Heene DL
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):967-80. PubMed ID: 2483715
[TBL] [Abstract][Full Text] [Related]
4. [Neutralization of low molecular weight heparin Kabi 2165 by protamine chloride].
Harenberg J; Giese C; Knödler A; Zimmermann R; Schettler G
Klin Wochenschr; 1986 Nov; 64(22):1171-5. PubMed ID: 3807263
[TBL] [Abstract][Full Text] [Related]
5. In vivo neutralization of unfractionated heparin and low-molecular-weight heparin by a novel salicylamide derivative.
Kuziej J; Litinas E; Hoppensteadt DA; Liu D; Walenga JM; Fareed J; Jeske W
Clin Appl Thromb Hemost; 2010 Aug; 16(4):377-86. PubMed ID: 20460347
[TBL] [Abstract][Full Text] [Related]
6. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
[TBL] [Abstract][Full Text] [Related]
7. In-vitro and ex-vivo neutralizing effect of protamine sulphate on the anticoagulant activity of a new low molecular mass heparin.
Falkon L; Garí M; Gich I; Fontcuberta J
Thromb Res; 1998 Jan; 89(2):79-83. PubMed ID: 9630311
[No Abstract] [Full Text] [Related]
8. Partial in vivo neutralisation of plasma anticoagulant effects of Lomoparan (Org 10172) by protamine chloride.
Stiekema JC; Wijnand HP; ten Cate H; ten Cate JW; Harenberg J; Egberts JF; van Dinther TG
Thromb Res; 1991 Jul; 63(1):157-67. PubMed ID: 1948817
[TBL] [Abstract][Full Text] [Related]
9. Andexanet Alfa Neutralizes the Anticoagulant Effects of Unfractionated Heparin of Bovine, Ovine and Porcine Origin Almost as Protamine Sulfate.
Siddiqui F; Hoppensteadt D; Jeske W; Ramacciotti E; Tafur A; Fareed J
Clin Appl Thromb Hemost; 2024; 30():10760296241247558. PubMed ID: 38656136
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of low molecular weight heparin by protamine chloride in vivo.
Harenberg J; Gnasso A; de Vries JX; Zimmermann R; Augustin J
Thromb Res; 1985 Apr; 38(1):11-20. PubMed ID: 4002198
[TBL] [Abstract][Full Text] [Related]
11. Does protamine chloride neutralize low molecular weight heparin sufficiently?
Gram J; Mercker S; Bruhn HD
Thromb Res; 1988 Dec; 52(5):353-9. PubMed ID: 2851882
[TBL] [Abstract][Full Text] [Related]
12. Protamine neutralisation of low molecular weight heparins and their oligosaccharide components.
Schroeder M; Hogwood J; Gray E; Mulloy B; Hackett AM; Johansen KB
Anal Bioanal Chem; 2011 Jan; 399(2):763-71. PubMed ID: 20922518
[TBL] [Abstract][Full Text] [Related]
13. Confounding effect of therapeutic protamine and heparin levels on routine and special coagulation testing.
Khandelwal A; Phua CW; Chaudhry HR; Tsui H; Rivard GE; Teitel JM; Sholzberg M
Blood Coagul Fibrinolysis; 2020 Jan; 31(1):60-64. PubMed ID: 31904611
[TBL] [Abstract][Full Text] [Related]
14. Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation.
Massonnet-Castel S; Pelissier E; Bara L; Terrier E; Abry B; Guibourt P; Swanson J; Jaulmes B; Carpentier A; Samama M
Haemostasis; 1986; 16(2):139-46. PubMed ID: 3710291
[TBL] [Abstract][Full Text] [Related]
15. Neutralization of DHG, a new depolymerized holothurian glycosaminoglycan, by protamine sulfate and platelet factor 4.
Sasaki E; Minamiguchi K; Kitazato KT; Nagase H; Kitazato K
Haemostasis; 1997; 27(4):174-83. PubMed ID: 9483172
[TBL] [Abstract][Full Text] [Related]
16. Protamine neutralization of the release of tissue factor pathway inhibitor activity by heparins.
Harenberg J; Siegele M; Dempfle CE; Stehle G; Heene DL
Thromb Haemost; 1993 Dec; 70(6):942-5. PubMed ID: 8165616
[TBL] [Abstract][Full Text] [Related]
17. Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.
Gatt A; van Veen JJ; Woolley AM; Kitchen S; Cooper P; Makris M
Thromb Haemost; 2008 Aug; 100(2):350-5. PubMed ID: 18690358
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of Clivarin a new low molecular weight heparin in healthy volunteers.
Andrassy K; Eschenfelder V; Koderisch J; Weber E
Thromb Res; 1994 Jan; 73(2):95-108. PubMed ID: 7802862
[TBL] [Abstract][Full Text] [Related]
19. Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin). An experimental investigation in healthy volunteers.
Holst J; Lindblad B; Bergqvist D; Garre K; Nielsen H; Hedner U; Ostergaard PB
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):795-803. PubMed ID: 7865687
[TBL] [Abstract][Full Text] [Related]
20. The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man.
Holst J; Lindblad B; Bergqvist D; Hedner U; Nordfang O; Ostergaard P
Thromb Res; 1997 May; 86(4):343-8. PubMed ID: 9187023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
